Actinomucor elegans
Actinomucor elegans was originally described by Schostakowitsch in Siberia in 1898 and reevaluated by Benjamin and Hesseltine in 1957. Commonly found in soil and used for the commercial production of fermented tofu and other products made by soy fermentation. Its major identifying features are its spine-like projections on the sporangiophore and its ribbon-like hyphal structure when found in the tissue of a host.
Taxonomy
The Actinomucor genus has many shared similarities with the genus Mucor. The specific differences lie in the branched hyphae of Actinomucor that give rise to rhizoids and sporangiophores. In terms of its differences from other similar genera, the limited growth of hyphae and the variation in the structure of columella and sporangiophores give Actinomucor multiple differentiable characteristics to other genera.Morphology
Mycelial growths of A. elegans have a high number of rhizoids branching out of each individual growth. On portions of growth that lack opposite rhizoids, aseptate hyphal growths with clear sporangiophores that are found with extreme variability in length and width. These hyphal structures grow out in whorled structures with growth terminating in the development of sporangiophores. The sporangia are oval to spherical in shape and 17–50 μm in diameter. The walls of the sporangia possess prominent spine-like projections, which is a major identifier of this specific fungus. The coloration of colonies of this fungi is white to cream-colored with an abundance of aerial mycelium. Cultures allowed to develop for a longer period of time change to become yellowish to buff color with increased aerial mycelium development and tight interweaving of these mycelia. When this fungus is found in a human host the structure is explained to be similar to the genus Mucor, but with unique ribbon-like hyphal structures and irregular branching and thickness.Human pathogen
Identified as an arising human fungal pathogen the recorded instances of mucormycosis due to A. elegans are limited to four cases. The invasion mechanisms found for A. elegans are through spore inhalation or entry from ruptures in the skin. This pathogen is highly-deadly when found in an immunocompromised individual, and can develop into a serious infection for immunocompetent individuals as well. Immunocompromised patients are affected worse by infection due to their immune system being unable to stop the germination of fungal spores resulting in there being no mechanism to slow the colonization once this pathogen is introduced.In all cases involving immunocompromised individuals, the relatively large visible location of necrosis seemed to be the first indicator of an invasion. It is thought that these necrotic areas are indicative of the place on the body in which inoculation occurred. A. elegans as a pathogen is categorized as a mucormycosis-causing fungus, and because of this, the current leading treatment for this type of pathogen is the removal of necrotic tissue in an effort to remove the fungal elements from the body. The severity of infection from A. elegans is due to its propensity for invasion of the vascular system and hematogenous dispersion ultimately leading to necrosis of tissue. To limit the suffering, discomfort, or expiration of a patient infected with this pathogen an early suspicion of this specific fungi needs to be established. Early identification is important as it limits the time for the fungi to colonize the host before doctors can gather infected tissue to isolate and culture the fungi to confirm its presence in the patient. Because of this pathogen's relative rarity, the time required to correctly identify the pathogen is usually not rapid enough resulting in high mortality rates of individuals infected.